Clinical Trial Update: An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED) [Phase 3]

View source ↗

Summary

An investigational drug MK-0653A-043 AM4 completed a Phase 3 trial evaluating clinical outcomes in patients with aortic stenosis, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• MK-0653A-043 AM4

Snippet

Sponsor: Organon and Co | Conditions: Aortic Stenosis | Phase 3 | Status: COMPLETED | Results posted: 2009-05-27